SMTL ID : 6wib.1

Next generation monomeric IgG4 Fc

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.55 Å

Oligo State

monomer

Ligands

1 x NAG- NAG- BMA- MAN- NAG- MAN- NAG- FUC: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-[2-acetamido-2-deoxy-beta-D-glucopyranose-(1-2)-alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose

NAG-NAG-BMA-MAN-NAG-MAN-NAG-FUC.1: 11 residues within 4Å: Chain A: F.7, F.9, T.26, V.28, V.30, D.31, Q.61, N.63, T.65, R.67, K.100 1 PLIP interactions: 1 interactions with chain A Hydrophobic interactions: A:N.63

3 x ZN: ZINC ION(Non-covalent)

ZN.2: 1 residues within 4Å: Chain A: H.51 2 PLIP interactions: 1 interactions with chain A, 1 Ligand-Water interactions Metal complexes: A:H.51, H2O.1 ZN.3: 3 residues within 4Å: Chain A: H.76, L.80, H.201 2 PLIP interactions: 2 interactions with chain A Metal complexes: A:H.76, A:H.201 ZN.4: 1 residues within 4Å: Chain A: E.111 1 PLIP interactions: 1 interactions with chain A Metal complexes: A:E.111

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Shan, L. et al., In vivo pharmacokinetic enhancement of monomeric Fc and monovalent bispecific designs through structural guidance. Commun Biol (2021)

Release Date

2021-09-15

Peptides

Immunoglobulin heavy constant gamma 4: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Immunoglobulin heavy constant gamma 4